Active Supportive Care and Symptom Management Grants

PI Name Organization - Company Title FOAsort ascending
Levine, Jon David University Of California, San Francisco Chronic Chemotherapy Peripheral Neuropathy: Role of Neuroplasticity and Stress
Wang, Jing New York University School Of Medicine Optimizing the use of ketamine to reduce chronic postsurgical pain RFA-NS-20-028: HEAL Initiative: Pain Management Effectiveness Research Network: Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
Melemedjian, Ohannes Kevork University Of Maryland Baltimore Identification of novel targets for the treatment of chemotherapy-induced painful peripheral neuropathy RFA-NS-18-043: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment
Laack, Nadia N Mayo Clinic Rochester Utility of memantine in preventing cognitive dysfunction in children receiving cranial radiotherapy RFA-CA-19-033: Improving Outcomes for Pediatric, Adolescent and Young Adult Cancer Survivors
Hu, Shuiying Ohio State University Prevention of paclitaxel-induced peripheral neuropathy with nilotinib RFA-CA-18-019: Research Answers to National Cancer Institute's (NCI) Provocative Questions
Tighiouart, Mourad Cedars-Sinai Medical Center Advancing Analysis and Interpretation ofAdverse Events and PROs in Cancer Clinical Trials RFA-CA-17-052: Analyzing and Interpreting Clinician and Patient Adverse Event Data to Better Understand Tolerability
Mohile, Supriya G University Of Rochester Understanding Treatment Tolerability in Older Patients with Cancer RFA-CA-17-052: Analyzing and Interpreting Clinician and Patient Adverse Event Data to Better Understand Tolerability
Gray, Robert J Dana-Farber Cancer Inst Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV) RFA-CA-17-052: Analyzing and Interpreting Clinician and Patient Adverse Event Data to Better Understand Tolerability
Basch, Ethan M. Univ Of North Carolina Chapel Hill Analyzing and Interpreting PRO-CTCAE with CTCAE and Other Clinical Data to Characterize Drug Tolerability RFA-CA-17-052: Analyzing and Interpreting Clinician and Patient Adverse Event Data to Better Understand Tolerability
Grace, Peter University Of Tx Md Anderson Can Ctr PQ12 Targeting HDAC6 for Chemotherapy-Induced Neuropathy and Chemobrain RFA-CA-17-017: Research Answers to NCI's Provocative Questions
Prigerson, Holly Gwen Weill Medical Coll Of Cornell Univ Behavioral and Psychosocial Effects on Study Outcomes in End-Stage Cancer Treatment (BEST End-Stage Cancer Study) PAR-21-333: NCI Outstanding Investigator Award
Ross, Stephen New York University School Of Medicine Psilocybin Therapy for Advanced Cancer-related Psychiatric Distress PAR-21-035: Cancer Prevention and Control Clinical Trials Grant Program
Rini, Christine Northwestern University At Chicago Web-based Pain Coping Skills Training to Improve Pain and Poor Adherence caused by Aromatase Inhibitor-Associated Arthralgia In Breast Cancer Survivors (SKIP-Arthralgia): A Randomized Controlled Trial PAR-21-035: Cancer Prevention and Control Clinical Trials Grant Program
Valdimarsdottir, Heiddis Icahn School Of Medicine At Mount Sinai Systematic Light Exposure Effects on Circadian Rhythms Entrainment, Inflammation, Neutropenic Fever and Symptom Burden among Multiple Myeloma Patients undergoing Autologous Stem Cell Transplantation PAR-21-035: Cancer Prevention and Control Clinical Trials Grant Program
Hu, Jim Weill Medical Coll Of Cornell Univ Pelvic fascia spARing radical prostatectomy TrIAL (PARTIAL) PAR-21-035: Cancer Prevention and Control Clinical Trials Grant Program

Pages